Health in Portugal 1,327 indicators covering health for Portugal. IndicatorLatest Year10-yr change Rank Health care expenditure by function 31,878 2025 up 88.7% 15th Health care expenditure by financing scheme 31,878 2025 up 88.7% 15th Expenditure for selected health care functions by health care 31,878 2025 up 88.7% 15th Health care expenditure by provider 31,878 2025 up 88.7% 15th Expenditure for selected health care providers by health care 31,878 2025 up 88.7% 15th Expenditure for selected health care functions by health care 31,878 2025 up 88.7% 15th Persons having a longstanding health problem by level of disability 17 2025 up 4.9% 10th Self-perceived health by level of disability (activity limitation) 87.6 2025 up 5.5% 30th Healthy life expectancy based on self-perceived health 74.6 2024 up 9.1% 20th 1.1.1 Children living in households in extreme poverty 0.3136 2022 down 71.2% 37th Infant mortality by age and sex 50 2024 down 19.4% 22nd Number of imported cases of cutaneous leishmaniasis reported 0 2023 — 34th Number of imported cases of visceral leishmaniasis reported 1 2024 — 14th Health impacts of air pollution 22,894 2023 down 41.5% 21st Technical resources in hospital 922 2024 up 2.2% 12th Tsunami deaths 69 1980 up 176.0% 5th Deaths related to infectious diseases 1,339 2023 up 8.4% 12th Causes of death - infant mortality by country of occurrence 218 2023 down 11.4% 18th Fetal, peri- and neonatal mortality rates by country of occurrence 3.9 2023 up 30.0% 17th Peri-neonatal mortality by age of mother, country of residence and 336 2023 up 36.0% 14th Reported cases of gonorrhea 2,280 2023 up 2,071.4% 16th Reported cases of syphilis 1,153 2023 up 643.9% 13th Causes of death - potential years of life lost by treatable and 2,893 2023 down 10.4% 17th People having a long-standing illness or health problem, by sex, age 22.9 2025 down 8.8% 16th Treatable and preventable mortality of residents by cause and sex 21,474 2023 down 1.0% 14th Antimicrobial resistance or decreased susceptibiity (DS/R) to 59.1 2022 up 3,147.2% 1st Antimicrobial resistance or decreased susceptibiity (DS/R) to 110 2022 unchanged 31st Causes of death - infant mortality by country of residence 214 2023 down 11.9% 17th Influenza vaccination rate elderly oecd 60.8 2017 up 19.2% 18th Reported cases of chlamydia 1,404 2023 up 140,300.0% 18th Excess mortality by month 4.3 2026 down 79.6% 7th Consumption of antibiotics in the community and hospital sectors 20.8 2024 up 15.6% 13th Total use of antibacterials expressed as DDD per 1000 inhabitants per 19.75 2023 up 4.7% 23rd Pattern of antibiotic consumption at national level 63.11 2023 up 4.7% 25th Hospital days of in-patients - historical data 6.41 million 2021 down 3.9% 14th Hospital discharges by diagnosis, in-patients, total number 795,278 2021 down 12.6% 19th Hospital discharges by diagnosis, in-patients, per 100 000 7,702 2021 down 10.7% 25th Infant mortality by mother's educational attainment level (ISCED11f) 252 2024 up 6.8% 14th Imports in 1000s hectolitres 248 2007 up 7.8% 29th Hospital discharges by diagnosis, day cases, total number 851,546 2021 down 18.6% 9th Number of isolates tested for ceftriaxone 110 2020 up 52.8% 26th Proportion of isolates with decreased susceptibility or resistance 0 2020 — 13th Hospital discharges by diagnosis, day cases, per 100 000 inhabitants 8,247 2021 down 16.8% 7th Proportion of isolates with resistance to azithromycin reported to 15.4 2020 up 177.2% 9th Number of isolates tested for azithromycin 110 2020 up 52.8% 25th Proportion of isolates with resistance to ciprofloxacin reported to 32.8 2018 down 4.0% 49th Number of isolates tested for ciprofloxacin 122 2018 up 54.4% 27th 4.1.1 Proportion of children and young people at the end of lower 76.72 2018 up 0.6% 26th Proportion of isolates with decreased susceptibility or resistance 0 2018 — 25th Number of isolates tested for extended-spectrum cephalosporins 122 2018 up 54.4% 28th 4.1.1 Proportion of children and young people at the end of lower 79.78 2018 down 3.2% 17th Proportion of children at the end of lower secondary achieving at 76.2% 2015 up 10.0% 30th Exports of beer (barley) in 1000s hectolitres 1.99 2009 down 99.7% 79th Proportion of isolates with decreased susceptibility or resistance 0 2018 — 15th Number of isolates tested for cefixime 122 2018 up 54.4% 13th Civil registration coverage of cause-of-death 100.0% 2012 unchanged 1st Alcohol-related road traffic crashes with fatalities 5.5% 2008 up 103.7% 31st Alcohol-related road traffic crashes with fatalities 5.5% 2008 up 103.7% 31st Sales of wine in 1000s hectolitres 4.52 2007 down 1.6% 52nd Alcohol-related road traffic crashes with fatalities, per 100,000 0.5 2008 down 16.7% 20th ← Previous Page 22 of 23 Next →